204 related articles for article (PubMed ID: 11939268)
1. Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
Gotoh A; Miyazawa K; Uchida Y; Sashida G; Kawakubo K; Kuriyama Y; Ohyashiki K
Int J Hematol; 2002 Feb; 75(2):191-4. PubMed ID: 11939268
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia.
Mollee P; Arthur C; Hughes T; Januszewicz H; Grigg A; Bradstock K; Wolf M; Gibson J; Schwarer AP; Spencer A; Browett P; Hawkins T; Seldon M; Herrmann R; Watson A; Seymour JF; Martin N; Shina S; Low C; Wright S; Rodwell R; Coulston J; Morton J; Blacklock H; Taylor D; Taylor KM
Ann Oncol; 2004 Dec; 15(12):1810-5. PubMed ID: 15550587
[TBL] [Abstract][Full Text] [Related]
3. Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.
Maloisel F; Guerci A; Guyotat D; Ifrah N; Michallet M; Reiffers J; Tertain G; Blanc M; Bauduer F; Brière J; Abgrall JF; Pegourie-Bandelier B; Solary E; Cambier N; Coso D; Vilque JP; Delain M; Harousseau JL; Rousselot P; Belhadj K; Morice P; Attal J; Chabin M; Chastang C; Guilhot J; Guilhot F;
Leukemia; 2002 Apr; 16(4):573-80. PubMed ID: 11960335
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon.
Cervantes F; Sureda A; Hernández-Boluda JC; Martino R; Brunet S; Borrego D; Antich JL; Montserrat E
Haematologica; 2001 Dec; 86(12):1281-6. PubMed ID: 11726320
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of extramedullary blast crisis of chronic myelogenous leukemia with imatinib mesylate (STI571).
Naito K; Mori T; Miyazaki K; Tsukada Y; Ikeda Y; Okamoto S
Intern Med; 2003 Aug; 42(8):740-2. PubMed ID: 12924504
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.
Kühr T; Eisterer W; Apfelbeck U; Linkesch W; Bechter O; Zabernigg A; Geissler K; Barbieri G; Duba C; Gastl G; Thaler J
Leuk Res; 2000 Jul; 24(7):583-7. PubMed ID: 10867132
[TBL] [Abstract][Full Text] [Related]
7. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
8. Extramedullary blast crisis in a patient with chronic myelogenous leukemia in complete cytogenetic and molecular remission on interferon-alpha therapy.
Beedassy A; Topolsky D; Styler M; Crilley P
Leuk Res; 2000 Aug; 24(8):733-5. PubMed ID: 10936425
[TBL] [Abstract][Full Text] [Related]
9. [Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide].
Konaka Y; Namiuchi S
Rinsho Ketsueki; 1993 Dec; 34(12):1556-61. PubMed ID: 8295329
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.
Matsuda M; Morita Y; Shimada T; Miyatake J; Hirase C; Tanaka M; Tatsumi Y; Maeda Y; Kanamaru A
Int J Hematol; 2005 May; 81(4):307-9. PubMed ID: 15914360
[TBL] [Abstract][Full Text] [Related]
11. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
[TBL] [Abstract][Full Text] [Related]
12. An unusual case of extramedullary blast crisis in chronic myelocytic leukaemia.
Feng CS
Am J Hematol; 1988 Oct; 29(2):117-9. PubMed ID: 3189299
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary blast crisis in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic remission.
O'Brien S; Witt R; Talpaz M; Kantarjian H
Cancer; 1991 Apr; 67(7):1946-9. PubMed ID: 2004308
[TBL] [Abstract][Full Text] [Related]
14. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
[TBL] [Abstract][Full Text] [Related]
15. Lymph node blast crisis of chronic myelogenous leukemia. One case report.
Hwang SM; Chen TP; Liu HW; Lin SF; Chang CS; Liu TC; Yen JH; Tsai WJ
Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Jun; 6(6):302-8. PubMed ID: 2374182
[TBL] [Abstract][Full Text] [Related]
16. Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.
Kawakubo K; Ohyashiki JH; Ohyashiki K; Tauchi T; Ohto T; Toyama K
Cancer Genet Cytogenet; 1992 Feb; 58(2):165-8. PubMed ID: 1551082
[TBL] [Abstract][Full Text] [Related]
17. Fulminant bronchiolitis obliterans organizing pneumonia following 2 d of treatment with hydroxyurea, interferon-alpha and oral cytarabine ocfosfate for chronic myelogenous leukemia.
Kalambokis G; Stefanou D; Arkoumani E; Kitsanou M; Bourantas K; V Tsianos E
Eur J Haematol; 2004 Jul; 73(1):67-70. PubMed ID: 15182341
[TBL] [Abstract][Full Text] [Related]
18. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Martinelli G; Testoni N; Amabile M; Bonifazi F; De Vivo A; Farabegoli P; Terragna C; Montefusco V; Ottaviani E; Saglio G; Russo D; Baccarani M; Rosti G; Tura S
Bone Marrow Transplant; 2000 Apr; 25(7):729-36. PubMed ID: 10745258
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelogenous leukemia in the chronic phase with lymph node swelling which represented extramedullary involvement composed of cells at different stages of maturation.
Kobayashi Y; Tanaka T; Kawata E; Akaogi T
Rinsho Byori; 2011 Apr; 59(4):360-3. PubMed ID: 21618900
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid blast crisis during complete cytogenetic remission following interferon-alpha and hydroxyurea therapy.
Bose S; Chowdhry VP; Saxena R; Kucheria K
Acta Haematol; 1997; 98(3):155-9. PubMed ID: 9352747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
